BNP Paribas Financial Markets
KRTX

BNP Paribas Financial Markets’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

BNP Paribas Financial Markets’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-13,611
Closed -$4.31M – 4290
2023
Q4 		$4.31M Buy
13,611
+462
+4% +$89.8K ﹤0.01% 1506
2023
Q3 		$2.22M Buy
13,149
+6,013
+84% +$1.13M ﹤0.01% 1818
2023
Q2 		$1.55M Sell
7,136
-12,115
-63% -$2.6M ﹤0.01% 1914
2023
Q1 		$3.5M Sell
19,251
-14,820
-43% -$2.83M ﹤0.01% 1474
2022
Q4 		$6.69M Sell
34,071
-18,482
-35% -$3.96M 0.01% 1163
2022
Q3 		$11.8M Buy
52,553
+46,702
+798% +$9.45M 0.02% 898
2022
Q2 		$740K Buy
5,851
+3,985
+214% +$458K ﹤0.01% 2416
2022
Q1 		$237K Sell
1,866
-2,827
-60% -$318K ﹤0.01% 3068
2021
Q4 		$615K Buy
4,693
+652
+16% +$84.3K ﹤0.01% 2903
2021
Q3 		$494K Buy
4,041
+1,907
+89% +$220K ﹤0.01% 2753
2021
Q2 		$243K Buy
2,134
+144
+7% +$16.8K ﹤0.01% 2816
2021
Q1 		$239K Buy
1,990
+41
+2% +$4.64K ﹤0.01% 2954
2020
Q4 		$198K Sell
1,949
-1,777
-48% -$165K ﹤0.01% 2885
2020
Q3 		$288K Buy
3,726
+1,852
+99% +$158K ﹤0.01% 2542
2020
Q2 		$209K Sell
1,874
-1,570
-46% -$137K ﹤0.01% 2469
2020
Q1 		$248K Buy
3,444
+2,912
+547% +$249K ﹤0.01% 2749
2019
Q4 		$40.1K Sell
532
-47
-8% -$2.06K ﹤0.01% 3757
2019
Q3 		$9.45K Buy
+579
New +$11.3K ﹤0.01% 4161

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

BNP Paribas Financial Markets's KRTX Position: Q1 2024 in Review

BNP Paribas Financial Markets sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 13,611 shares — an estimated $4.31M sold.

BNP Paribas Financial Markets first reported a position in KRTX in Q3 2019 and held it in 18 quarters. The position peaked at $11.8M in Q3 2022. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • BNP Paribas Financial Markets reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 13,611 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $4.31M.
  • BNP Paribas Financial Markets first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2019 and held it in 18 quarters.
  • BNP Paribas Financial Markets's Karuna Therapeutics, Inc. Common Stock position peaked at $11.8M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2024, filed 1 May 2024.